首页>
外国专利>
GENETIC POLYMORPHISMS ASSOCIATED WITH STATIN RESPONSE AND CARDIOVASCULAR DISEASES, METHODS OF DETECTION AND USES THEREOF
GENETIC POLYMORPHISMS ASSOCIATED WITH STATIN RESPONSE AND CARDIOVASCULAR DISEASES, METHODS OF DETECTION AND USES THEREOF
展开▼
机译:他汀类药物反应和心血管疾病相关的遗传多态性,检测方法及其用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention provides a method for predicting responsiveness to statin treatment for reducing coronary heart disease (CHD) risk in a human, the method comprising testing a sample of nucleic acid from said human for the presence or absence of a single nucleotide polymorphism (SNP) in the nucleotide sequence of SEQ ID NO:3495 (rs1538185), wherein said human is determined to have an increased responsiveness to statin treatment for reducing CHD risk due to the presence of G at position 101 of SEQ ID NO:3495 or the presence of C at position 101 of its complement. Further provided are uses of a detection reagent and a kit for predicting said statin responsiveness in a human. The invention also provides said statin or a therapeutic agent for use in a method of treatment of CHD based on the detection of said SNP in the nucleotide sequence of SEQ ID NO:3495.
展开▼
机译:本发明提供了一种预测他汀类药物治疗对降低人冠心病(CHD)风险的反应性的方法,该方法包括测试来自所述人的核酸样品中是否存在单核苷酸多态性(SNP)。 SEQ ID NO:3495(rs1538185)的核苷酸序列,其中所述人被确定对他汀类药物治疗具有降低的CHD风险,这是由于SEQ ID NO:3495的101位存在G或C在其补码的第101位。还提供了检测试剂和试剂盒用于预测人中他汀类药物反应性的用途。本发明还提供了基于在SEQ ID NO:3495的核苷酸序列中的所述SNP的检测,用于所述CHD治疗方法的所述他汀或治疗剂。
展开▼